AVH.AX - Avita Medical Limited

ASX - ASX Delayed Price. Currency in AUD

Avita Medical Limited

28159 Avenue Stanford
Suite 220
Valencia, CA 91355
United States

IndustryMedical Appliances & Equipment
Full Time Employees37

Key Executives

Dr. Michael S. Perry DVM, Ph.D., FACVPTCEO & Exec. Director53.54kN/A59
Mr. Timothy RooneyChief Admin. OfficerN/AN/AN/A
Mr. Andrew QuickSr. VP of Clinical Devel.N/AN/AN/A
Mr. Gabriel Mario Chiappini B.Bus, CA, GAICD, B.Com, ICAA, MAICDCompany Sec.N/AN/AN/A
Mr. Adam KelliherConsultant623.82kN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Avita Medical Limited, a medical device company, develops and distributes regenerative products for the treatment of a range of wounds, scars, and skin defects in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. Its patented and proprietary collection and application technology provides treatment solutions derived from a patient's own skin. The company's lead product, ReCell, is used in the treatment of various burns, plastic, reconstructive, and cosmetic procedures. It also offers ReGenerCell for chronic wounds and ReNovaCell for pigmentation. Avita Medical Limited is based in Valencia, California.

Corporate Governance

Avita Medical Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.